(15008931), J. S. W., (15054769), H. T., (15054772), J. A. E., (15054775), N. M. A., (15054778), B. S., (15054781), H. B., . . . (14932995), M. A. D. (2025). Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases.
Chicagoスタイル(17版)引用形式(15008931), James S. Wilmott, et al. Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib Plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases. 2025.
MLA(9版)引用形式(15008931), James S. Wilmott, et al. Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib Plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases. 2025.